Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BUDOLFI HØREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.6% 3.6%   Bankruptcy risk   1.0% 1.1% 2.3% 1.3% 3.2% 1.6% 15.1% 14.7%   Credit score (0-100)   88 85 64 79 55 73 14 14   Credit rating   A A BBB A BBB A BB BB   Credit limit (kDKK)   164.5 107.9 0.0 44.7 0.0 3.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,108 2,615 3,487 3,084 2,689 2,563 0.0 0.0   EBITDA   930 765 612 1,373 808 636 0.0 0.0   EBIT   891 725 557 1,279 714 553 0.0 0.0   Pre-tax profit (PTP)   1,100.0 708.0 186.0 1,445.0 68.6 565.8 0.0 0.0   Net earnings   903.0 549.0 -205.0 1,165.0 -87.8 445.9 0.0 0.0   Pre-tax profit without non-rec. items   1,100 708 186 1,445 68.6 566 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,091 2,051 611 534 458 385 0.0 0.0   Shareholders equity total   2,099 2,149 1,444 2,108 521 967 342 342   Interest-bearing liabilities   1,682 1,588 413 86.0 142 190 0.0 0.0   Balance sheet total (assets)   4,663 4,851 3,755 3,490 1,429 1,740 342 342   Net Debt   1,675 1,583 -491 -454 19.3 186 -342 -342     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,108 2,615 3,487 3,084 2,689 2,563 0.0 0.0   Gross profit growth   -40.1% -15.9% 33.3% -11.6% -12.8% -4.7% -100.0% 0.0%   Employees   4 4 3 3 3 4 0 0   Employee growth %   0.0% 0.0% -25.0% 0.0% 0.0% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,663 4,851 3,755 3,490 1,429 1,740 342 342   Balance sheet change%   -14.3% 4.0% -22.6% -7.1% -59.1% 21.8% -80.4% 0.0%   Added value   930.0 765.0 612.0 1,373.0 807.9 635.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -40 -80 -1,452 -188 -186 -165 -385 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.7% 27.7% 16.0% 41.5% 26.5% 21.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.3% 15.5% 4.6% 40.1% 3.3% 36.4% 0.0% 0.0%   ROI %   30.2% 19.4% 7.0% 69.5% 5.6% 63.4% 0.0% 0.0%   ROE %   34.1% 25.8% -11.4% 65.6% -6.7% 60.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   45.0% 44.3% 38.5% 60.4% 36.4% 55.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   180.1% 206.9% -80.2% -33.1% 2.4% 29.3% 0.0% 0.0%   Gearing %   80.1% 73.9% 28.6% 4.1% 27.2% 19.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.7% 1.8% 1.4% 3.2% 11.1% 6.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.4 0.6 1.0 0.7 0.9 0.0 0.0   Current Ratio   0.5 0.7 0.9 1.3 0.9 1.5 0.0 0.0   Cash and cash equivalent   7.0 5.0 904.0 540.0 122.5 3.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -997.0 -731.0 -129.0 416.0 -93.1 411.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   233 191 204 458 269 159 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   233 191 204 458 269 159 0 0   EBIT / employee   223 181 186 426 238 138 0 0   Net earnings / employee   226 137 -68 388 -29 111 0 0